Literature DB >> 20145515

Mesenchymal stem-cell immunosuppressive capabilities: therapeutic implications in islet transplantation.

Yunchuan Ding1, Andrew Bushell, Kathryn J Wood.   

Abstract

Mesenchymal stem cells (MSCs) are known to be capable of suppressing immune responses and offer therapeutic potential for achieving transplantation tolerance. This review will discuss the impacts of MSCs on transplant immunity and focus on the potential role of MSCs in protecting islet grafts from both rejection and autoimmune attack.

Entities:  

Mesh：

Year:  2010        PMID： 20145515      PMCID： PMC4452939          DOI： 10.1097/TP.0b013e3181c6ffbe

Source DB:  PubMed          Journal:  Transplantation        ISSN： 0041-1337            Impact factor:   4.939


  26 in total

1.  Treatment of severe acute graft-versus-host disease with third party haploidentical mesenchymal stem cells.

Authors:  Katarina Le Blanc; Ida Rasmusson; Berit Sundberg; Cecilia Götherström; Moustapha Hassan; Mehmet Uzunel; Olle Ringdén
Journal:  Lancet       Date:  2004-05-01       Impact factor: 79.321

2.  Bone marrow mesenchymal stem cells suppress lymphocyte proliferation in vitro but fail to prevent graft-versus-host disease in mice.

Authors:  Muriel Sudres; Françoise Norol; Aurélie Trenado; Sylvie Grégoire; Frédéric Charlotte; Béatrice Levacher; Jean-Jacques Lataillade; Philippe Bourin; Xavier Holy; Jean-Paul Vernant; David Klatzmann; José L Cohen
Journal:  J Immunol       Date:  2006-06-15       Impact factor: 5.422

3.  Human mesenchymal stem cells modulate B-cell functions.

Authors:  Anna Corcione; Federica Benvenuto; Elisa Ferretti; Debora Giunti; Valentina Cappiello; Francesco Cazzanti; Marco Risso; Francesca Gualandi; Giovanni Luigi Mancardi; Vito Pistoia; Antonio Uccelli
Journal:  Blood       Date:  2005-09-01       Impact factor: 22.113

4.  Mesenchymal stem cells suppress lymphocyte proliferation in vitro and prolong skin graft survival in vivo.

Authors:  Amelia Bartholomew; Cord Sturgeon; Mandy Siatskas; Karen Ferrer; Kevin McIntosh; Sheila Patil; Wayne Hardy; Steve Devine; David Ucker; Robert Deans; Annemarie Moseley; Ronald Hoffman
Journal:  Exp Hematol       Date:  2002-01       Impact factor: 3.084

5.  Donor-derived mesenchymal stem cells are immunogenic in an allogeneic host and stimulate donor graft rejection in a nonmyeloablative setting.

Authors:  Alma J Nauta; Geert Westerhuis; Alwine B Kruisselbrink; Ellie G A Lurvink; Roel Willemze; Willem E Fibbe
Journal:  Blood       Date:  2006-05-11       Impact factor: 22.113

6.  International trial of the Edmonton protocol for islet transplantation.

Authors:  A M James Shapiro; Camillo Ricordi; Bernhard J Hering; Hugh Auchincloss; Robert Lindblad; R Paul Robertson; Antonio Secchi; Mathias D Brendel; Thierry Berney; Daniel C Brennan; Enrico Cagliero; Rodolfo Alejandro; Edmond A Ryan; Barbara DiMercurio; Philippe Morel; Kenneth S Polonsky; Jo-Anna Reems; Reinhard G Bretzel; Federico Bertuzzi; Tatiana Froud; Raja Kandaswamy; David E R Sutherland; George Eisenbarth; Miriam Segal; Jutta Preiksaitis; Gregory S Korbutt; Franca B Barton; Lisa Viviano; Vicki Seyfert-Margolis; Jeffrey Bluestone; Jonathan R T Lakey
Journal:  N Engl J Med       Date:  2006-09-28       Impact factor: 91.245

7.  Mesenchymal stem cells can induce long-term acceptance of solid organ allografts in synergy with low-dose mycophenolate.

Authors:  F C Popp; E Eggenhofer; P Renner; P Slowik; S A Lang; H Kaspar; E K Geissler; P Piso; H J Schlitt; M H Dahlke
Journal:  Transpl Immunol       Date:  2008-08-30       Impact factor: 1.708

8.  IFN-gamma activation of mesenchymal stem cells for treatment and prevention of graft versus host disease.

Authors:  David Polchert; Justin Sobinsky; Gw Douglas; Martha Kidd; Ada Moadsiri; Eduardo Reina; Kristyn Genrich; Swati Mehrotra; Suman Setty; Brett Smith; Amelia Bartholomew
Journal:  Eur J Immunol       Date:  2008-06       Impact factor: 5.532

9.  Mesenchymal stem cells: a potential border patrol for transplanted islets?

Authors:  Todd M Brusko
Journal:  Diabetes       Date:  2009-08       Impact factor: 9.461

10.  Cellular islet autoimmunity associates with clinical outcome of islet cell transplantation.

Authors:  Volkert A L Huurman; Robert Hilbrands; Gabriëlle G M Pinkse; Pieter Gillard; Gaby Duinkerken; Pieter van de Linde; Petronella M W van der Meer-Prins; Minke F J Versteeg-van der Voort Maarschalk; Koen Verbeeck; Behrooz Z Alizadeh; Chantal Mathieu; Frans K Gorus; Dave L Roelen; Frans H J Claas; Bart Keymeulen; Daniel G Pipeleers; Bart O Roep
Journal:  PLoS One       Date:  2008-06-18       Impact factor: 3.240
View more
  13 in total

1.  Mesenchymal stem cells differentially mediate regulatory T cells and conventional effector T cells to protect fully allogeneic islet grafts in mice.

Authors:  D M Xu; X F Yu; D Zhang; M X Zhang; J F Zhou; P H Tan; Y C Ding
Journal:  Diabetologia       Date:  2012-01-20       Impact factor: 10.122

2.  Intravenous mesenchymal stem cells prevented rejection of allogeneic corneal transplants by aborting the early inflammatory response.

Authors:  Joo Youn Oh; Ryang Hwa Lee; Ji Min Yu; Jung Hwa Ko; Hyun Ju Lee; Ah Young Ko; Gavin W Roddy; Darwin J Prockop
Journal:  Mol Ther       Date:  2012-08-28       Impact factor: 11.454

Review 3.  Cell-based liver therapies: past, present and future.

Authors:  Valeria Iansante; Anil Chandrashekran; Anil Dhawan
Journal:  Philos Trans R Soc Lond B Biol Sci       Date:  2018-07-05       Impact factor: 6.237

4.  Insulin-producing cells from adult human bone marrow mesenchymal stem cells control streptozotocin-induced diabetes in nude mice.

Authors:  Mahmoud M Gabr; Mahmoud M Zakaria; Ayman F Refaie; Amani M Ismail; Mona A Abou-El-Mahasen; Sylvia A Ashamallah; Sherry M Khater; Sawsan M El-Halawani; Rana Y Ibrahim; Gan Shu Uin; Malgorzata Kloc; Roy Y Calne; Mohamed A Ghoneim
Journal:  Cell Transplant       Date:  2012-06-15       Impact factor: 4.064

5.  In vitro reprogramming of rat bmMSCs into pancreatic endocrine-like cells.

Authors:  Hong-Tu Li; Fang-Xu Jiang; Ping Shi; Tao Zhang; Xiao-Yu Liu; Xue-Wen Lin; Zhong-Yan San; Xi-Ning Pang
Journal:  In Vitro Cell Dev Biol Anim       Date:  2016-10-03       Impact factor: 2.416

6.  Mesenchymal Stromal Cells as a Therapeutic Strategy to Support Islet Transplantation in Type 1 Diabetes Mellitus.

Authors:  Sarah A Busch; Saskia T J van Crutchen; Robert J Deans; Anthony E Ting
Journal:  Cell Med       Date:  2011-10-01

7.  Genetically engineered islets and alternative sources of insulin-producing cells for treating autoimmune diabetes: quo vadis?

Authors:  Feng-Cheng Chou; Shing-Hwa Huang; Huey-Kang Sytwu
Journal:  Int J Endocrinol       Date:  2012-05-29       Impact factor: 3.257

8.  Altered tryptophan metabolism as a paradigm for good and bad aspects of immune privilege in chronic inflammatory diseases.

Authors:  Lingqian Li; Lei Huang; Henrique P Lemos; Mario Mautino; Andrew L Mellor
Journal:  Front Immunol       Date:  2012-05-11       Impact factor: 7.561

9.  Mesenchymal stem cell therapy in diabetes mellitus: progress and challenges.

Authors:  Nagwa El-Badri; Mohamed A Ghoneim
Journal:  J Nucleic Acids       Date:  2013-05-15

10.  A new home for pancreatic islet transplants: the bone marrow.

Authors:  Antonello Pileggi; Camillo Ricordi
Journal:  Diabetes       Date:  2013-10       Impact factor: 9.461
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.